Income Statement - Taysha Gene Therapies, Inc. (TSHA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 9.77 | 8.33 | 15.45 | 2.50 | 0.00 | 0.00 | |
| Cost of revenue | 1.15 | 1.25 | 1.37 | 2.49 | 0.49 | 0.01 | |
| Gross profit | 9.77 | 8.33 | 15.45 | 0.01 | -0.49 | -0.01 | |
| Total operating expenses | 120.27 | 99.79 | 87.89 | 126.04 | 173.27 | 42.99 | 1.12 |
| Operating income | -110.50 | -91.46 | -72.44 | -126.03 | -173.27 | -43.00 | -1.12 |
| Non-operating income (net) | 1.50 | 2.16 | -39.13 | -39.99 | -1.26 | -17.01 | 0.00 |
| Income before tax | -109.00 | -89.30 | -111.57 | -166.01 | -174.52 | -60.01 | -1.12 |
| Income tax expense | -89.30 | 1.20 | 3.57 | 0.94 | -17.01 | -4.46 | |
| Net income | -109.00 | -89.30 | -111.57 | -166.01 | -174.52 | -43.00 | -1.12 |
Show Quarterly Income Statement
Income Statement - Taysha Gene Therapies, Inc. (TSHA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 5.49 | 0.00 | 1.99 | 2.30 | 2.02 | 1.79 | 1.11 | 3.41 | 3.60 | 4.75 | 2.40 | 4.71 | 2.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of revenue | 0.30 | 0.30 | 0.29 | 0.28 | -0.63 | 0.30 | 0.33 | 0.37 | 0.33 | 0.70 | 0.63 | 1.68 | 0.30 | 0.30 | 0.26 | 0.21 | 0.17 | 0.09 | 0.03 | |||||||
| Gross profit | -0.30 | 5.19 | -0.29 | 1.99 | 2.30 | 2.02 | 1.79 | 1.11 | 3.41 | 3.60 | 4.42 | 1.69 | 4.08 | 0.82 | -0.30 | -0.30 | -0.26 | -0.21 | -0.17 | -0.09 | -0.03 | |||||
| Total operating expenses | 43.19 | 33.49 | 33.74 | 28.74 | 23.72 | 21.95 | 27.69 | 22.41 | 27.74 | 19.85 | 20.05 | 25.08 | 20.63 | 21.20 | 25.46 | 33.37 | 49.65 | 49.72 | 50.68 | 40.77 | 32.09 | 18.37 | 15.04 | 4.01 | 5.58 | 1.12 |
| Operating income | -43.49 | -28.30 | -34.02 | -26.75 | -21.42 | -19.93 | -25.90 | -21.30 | -24.33 | -16.25 | -15.63 | -23.38 | -16.56 | -55.12 | -25.46 | -33.37 | -49.65 | -49.72 | -50.68 | -40.77 | -32.09 | -18.37 | -15.04 | -4.01 | -5.58 | -1.12 |
| Non-operating income (net) | 1.08 | 0.45 | 1.29 | -0.13 | -0.11 | 1.15 | 0.37 | 0.37 | 0.27 | 63.99 | -101.45 | -1.21 | -1.06 | -0.60 | -1.07 | -0.72 | -0.67 | -0.66 | -0.51 | -0.15 | 0.07 | 0.05 | 0.00 | -17.21 | 0.15 | 0.00 |
| Income before tax | -42.41 | -27.85 | -32.73 | -26.88 | -21.53 | -18.79 | -25.52 | -20.93 | -24.06 | 47.74 | -117.09 | -24.60 | -17.62 | -55.72 | -26.53 | -34.09 | -50.32 | -50.39 | -51.19 | -40.93 | -32.02 | -18.32 | -15.04 | -21.22 | -5.43 | -1.12 |
| Income tax expense | -0.28 | 0.28 | -3.55 | -0.33 | 1.44 | 2.44 | 2.33 | 1.23 | 0.89 | 0.84 | 0.69 | 0.04 | 0.04 | 0.07 | 0.05 | 0.00 | -21.22 | 0.03 | -1.16 | |||||||
| Net income | -42.41 | -27.85 | -32.73 | -26.88 | -21.53 | -18.79 | -25.52 | -20.93 | -24.06 | 47.74 | -117.09 | -24.60 | -17.62 | -58.06 | -26.53 | -34.09 | -50.32 | -50.39 | -51.19 | -40.93 | -32.02 | -18.32 | -15.04 | -21.22 | -5.43 | -1.12 |